KORU Medical Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of KORU Medical Systems generated cash of -$4,892,553, which is more than the previous year. Cash used in financing activities reached the amount of -$218,867 last year. Net change in cash is therefore -$5,926,017.
Cash Flow
| 2012 | 560.60K | -339.06K | 213.43K |
|---|---|---|---|
| 2013 | 784.79K | -568.19K | -43.49K |
| 2016 | 1.91M | -189.52K | -80.57K |
| 2017 | 899.91K | -219.28K | -19.36K |
| 2018 | 1.47M | -1.72M | 14.42K |
| 2019 | 320.62K | 1.31M | 501.29K |
| 2020 | -743.32K | -1.03M | 23.22M |
| 2021 | -4.31M | -366.16K | 2.70M |
| 2022 | -5.40M | -2.80M | 279.48K |
| 2023 | -4.89M | -814.59K | -218.86K |
KRMD Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 17.40M | 25.33M | 27.31M | 5.87M | 3.73M | 3.97M | 4.20M | 2.55M | 1.75M | 1.32M |
Operating activities | ||||||||||
Net income | -13.74M | -8.66M | -4.56M | -1.21M | 564.34K | 910.57K | 1.08M | 782.86K | 725.76K | 815.89K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 870.39K | 587.13K | 463.13K | 418.59K | 340.22K | 309.26K | 308.70K | 271.56K | 190.97K | 103.98K |
Stock-based compensation expense | 2.76M | 3.07M | 2.70M | 1.61M | 1.20M | 0 | 129.7K | 114.55K | 80.1K | 0 |
| Deferred income tax benefit | 2.76M | 3.07M | 2.70M | 1.61M | 1.20M | 0 | 129.7K | 114.55K | 80.1K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 457.18K | 34.00K | -1.01M | 669.74K | -1.80M | 475.66K | -418.86K | 286.42K | -230.12K | -170.82K |
Inventories | 2.92M | -298.52K | 723.43K | -4.44M | -284.59K | -445.19K | -304.97K | 186.35K | 17.32K | -499.25K |
Accounts payable | -1.41M | 1.16M | 602.61K | 52.26K | 119.15K | -900 | -318.03K | 64.54K | -89.16K | 41.41K |
Cash generated by operating activities | -4.89M | -5.40M | -4.31M | -743.32K | 320.62K | 1.47M | 899.91K | 1.91M | 784.79K | 560.60K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 6.54K | -1.5M | 0 | -1.32K | -1.78K | -102.82K |
Investments In Property Plant And Equipment | -782.94K | -2.80M | -375.23K | -1.06M | -425.53K | -481.16K | -218.32K | -201.74K | -566.41K | -236.23K |
Acquisitions Net | 0 | 0 | 9.06K | 25K | 217.82K | 481.16K | 0 | 13.55K | 0 | 0 |
Cash generated by investing activities | -814.59K | -2.80M | -366.16K | -1.03M | 1.31M | -1.72M | -219.28K | -189.52K | -568.19K | -339.06K |
Financing activities | ||||||||||
Common Stock Issued | 446.34K | 406.62K | 2.19M | 26.72M | 508.9K | 51.25K | 0 | 0 | 263.7K | 121.5K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -3.49M | -2.82K | -36.82K | -19.36K | -80.57K | 0 | 0 |
Repayments of term debt | -185.40K | -127.13K | -418.45K | -4.98M | -4.78K | 0 | 0 | 0 | -43.49K | -1.92K |
Cash used in financing activities | -218.86K | 279.48K | 2.70M | 23.22M | 501.29K | 14.42K | -19.36K | -80.57K | -43.49K | 213.43K |
Net Change In Cash | -5.92M | -7.92M | -1.98M | 21.44M | 2.13M | -235.73K | -227.41K | 1.64M | 173.09K | 434.97K |
Cash at end of period | 11.48M | 17.40M | 25.33M | 27.31M | 5.87M | 3.73M | 3.97M | 4.20M | 1.93M | 1.75M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |